Cargando…
Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome?
Coronavirus disease 2019 (COVID-19) patients can develop interstitial pneumonia, which, in turn, can evolve into acute respiratory distress syndrome (ARDS). This is accompanied by an inflammatory cytokine storm. severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has proteins capable o...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564484/ https://www.ncbi.nlm.nih.gov/pubmed/32967358 http://dx.doi.org/10.3390/jcm9093045 |
_version_ | 1783595725762854912 |
---|---|
author | Falcone, Carmela Caracciolo, Massimo Correale, Pierpaolo Macheda, Sebastiano Vadalà, Eugenio Giuseppe La Scala, Stefano Tescione, Marco Danieli, Roberta Ferrarelli, Anna Tarsitano, Maria Grazia Romano, Lorenzo De Lorenzo, Antonino |
author_facet | Falcone, Carmela Caracciolo, Massimo Correale, Pierpaolo Macheda, Sebastiano Vadalà, Eugenio Giuseppe La Scala, Stefano Tescione, Marco Danieli, Roberta Ferrarelli, Anna Tarsitano, Maria Grazia Romano, Lorenzo De Lorenzo, Antonino |
author_sort | Falcone, Carmela |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) patients can develop interstitial pneumonia, which, in turn, can evolve into acute respiratory distress syndrome (ARDS). This is accompanied by an inflammatory cytokine storm. severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has proteins capable of promoting the cytokine storm, especially in patients with comorbidities, including obesity. Since currently no resolutive therapy for ARDS has been found and given the scientific literature regarding the use of adenosine, its application has been hypothesized. Through its receptors, adenosine is able to inhibit the acute inflammatory process, increase the protection capacity of the epithelial barrier, and reduce the damage due to an overactivation of the immune system, such as that occurring in cytokine storms. These features are known in ischemia/reperfusion models and could also be exploited in acute lung injury with hypoxia. Considering these hypotheses, a COVID-19 patient with unresponsive respiratory failure was treated with adenosine for compassionate use. The results showed a rapid improvement of clinical conditions, with negativity of SARS-CoV2 detection. |
format | Online Article Text |
id | pubmed-7564484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75644842020-10-26 Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome? Falcone, Carmela Caracciolo, Massimo Correale, Pierpaolo Macheda, Sebastiano Vadalà, Eugenio Giuseppe La Scala, Stefano Tescione, Marco Danieli, Roberta Ferrarelli, Anna Tarsitano, Maria Grazia Romano, Lorenzo De Lorenzo, Antonino J Clin Med Review Coronavirus disease 2019 (COVID-19) patients can develop interstitial pneumonia, which, in turn, can evolve into acute respiratory distress syndrome (ARDS). This is accompanied by an inflammatory cytokine storm. severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has proteins capable of promoting the cytokine storm, especially in patients with comorbidities, including obesity. Since currently no resolutive therapy for ARDS has been found and given the scientific literature regarding the use of adenosine, its application has been hypothesized. Through its receptors, adenosine is able to inhibit the acute inflammatory process, increase the protection capacity of the epithelial barrier, and reduce the damage due to an overactivation of the immune system, such as that occurring in cytokine storms. These features are known in ischemia/reperfusion models and could also be exploited in acute lung injury with hypoxia. Considering these hypotheses, a COVID-19 patient with unresponsive respiratory failure was treated with adenosine for compassionate use. The results showed a rapid improvement of clinical conditions, with negativity of SARS-CoV2 detection. MDPI 2020-09-21 /pmc/articles/PMC7564484/ /pubmed/32967358 http://dx.doi.org/10.3390/jcm9093045 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Falcone, Carmela Caracciolo, Massimo Correale, Pierpaolo Macheda, Sebastiano Vadalà, Eugenio Giuseppe La Scala, Stefano Tescione, Marco Danieli, Roberta Ferrarelli, Anna Tarsitano, Maria Grazia Romano, Lorenzo De Lorenzo, Antonino Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome? |
title | Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome? |
title_full | Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome? |
title_fullStr | Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome? |
title_full_unstemmed | Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome? |
title_short | Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome? |
title_sort | can adenosine fight covid-19 acute respiratory distress syndrome? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564484/ https://www.ncbi.nlm.nih.gov/pubmed/32967358 http://dx.doi.org/10.3390/jcm9093045 |
work_keys_str_mv | AT falconecarmela canadenosinefightcovid19acuterespiratorydistresssyndrome AT caracciolomassimo canadenosinefightcovid19acuterespiratorydistresssyndrome AT correalepierpaolo canadenosinefightcovid19acuterespiratorydistresssyndrome AT machedasebastiano canadenosinefightcovid19acuterespiratorydistresssyndrome AT vadalaeugeniogiuseppe canadenosinefightcovid19acuterespiratorydistresssyndrome AT lascalastefano canadenosinefightcovid19acuterespiratorydistresssyndrome AT tescionemarco canadenosinefightcovid19acuterespiratorydistresssyndrome AT danieliroberta canadenosinefightcovid19acuterespiratorydistresssyndrome AT ferrarellianna canadenosinefightcovid19acuterespiratorydistresssyndrome AT tarsitanomariagrazia canadenosinefightcovid19acuterespiratorydistresssyndrome AT romanolorenzo canadenosinefightcovid19acuterespiratorydistresssyndrome AT delorenzoantonino canadenosinefightcovid19acuterespiratorydistresssyndrome |